Pulmonary hypertension with connective tissue disease
Part of Heart & circulation, Lungs & breathing, Skin clinical trials.
This trial is studying people who have both a connective tissue disease (like lupus or scleroderma) and pulmonary hypertension, which is high blood pressure in the lungs. By participating, doctors can learn more about how to better treat this combination.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a connective tissue disease like lupus, Sjogren's syndrome, scleroderma, mixed connective tissue disease, overlap syndrome, rheumatoid arthritis, or an undifferentiated form.
- You must have pulmonary hypertension confirmed by a right heart catheterization (a test that measures pressures in your heart and lungs).
- Your pulmonary hypertension should not be primarily due to other causes such as lung disease, heart disease, blood clots, liver disease, HIV, or drug exposure.
- You must be at least 18 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects health information from people with certain types of pulmonary hypertension linked to connective tissue diseases. It helps doctors understand patterns of disease and outcomes, which can guide future care and studies.
This study looks at people aged 18 and older who have a connective tissue disease and lung involvement. It aims to better understand how these lung problems progress and may help doctors choose better care.
This study looks at people with connective tissue diseases who also have lung problems. It helps doctors understand and manage these lung issues better.
This study is testing whether a new risk score can better predict outcomes for people who have both chronic lung disease and pulmonary hypertension (high blood pressure in the lungs). If you qualify, the researchers will follow your health over time to see how well the score works.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This study collects and stores health information and possibly blood samples from people being evaluated for pulmonary hypertension or related autoimmune conditions. It helps researchers learn more about these illnesses and may support future studies.
Hear when a new Connective Tissue Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.